Labrida AS


The Board

Tore Heldrup Rasmussen (MBA), Chairman of the board:

  • Rasmussen has held board and chairman positions at several public and stock listed companies, including Natural ASA, Aker BioMarine ASA, NSB (Norwegian railroads) and Sarsia Life Science Fund. He has industrial background from Procter & Gamble Inc and Orkla ASA, founder/partner at Markup Consulting and EVP commercial at Norwegian Property ASA. He has been instrumental in developing several early stage Life Science companies.

Svein Harald Øygard, Board member:

  • Svein Harald Øygard is a gründer, advisor and investor. He has worked as an advisor for i.a. Sparabank 1 Markets since 2017. He was previously with McKinsey for about 20 years, also leading McKinsey Norway. He served clients in industry, energy, finance, health and the public sector. He was also interim Central Bank Governor of Iceland after the 2008 crisis and Deputy Minister of Finance of Norway 1990-94.

Lars Viksmoen, Board member:

  • Text to be updated

Anders Holmén (DDS), Board member:

  • Holmén has more than 25 years’ experience from the dental implant industry, in positions as clinical director and head of Product and therapy management in Astra Tech (now Dentsply, Inc.). He has also been assistant professor at Göteborg’s University and visiting professor at University of Connecticut.

Kathryn M. Baker (MBA), Board member:

  • Baker has six years experience from McKinsey & Co as well as 15 years at Private Equity (Reiten & co). She serves as board member of several listed companies, including AKASTOR (Aker Solutions ASA), Sevan Marine ASA and Agasti Holding. She is also at the board of directors at Bank of Norway.